Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade Gliomas Kripa Guram, BS, Mark Smith,

Slides:

Advertisements

Similar presentations

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes Stuart E. Samuels, MD, PhD, Matthew.

Advertisements

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer Victor E. Chen, BS, Erin.

Management of independent motion between multiple targets in lung cancer radiation therapy Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity Sarah J. Stephens, MD, Samantha Thomas, MB,

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions Chelsea.

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy Fady F. Youssef, MS, Parag.

Survival of young patients after abdominal aortic aneurysm repair

Aaron S. Kusano, MD, SM, Matthew J

David J. Hoopes, MD, Adam P. Dicker, MD, PhD, Nadine L

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.

US radiation oncology practice patterns for posttreatment survivor care Bridget F. Koontz, MD, Rashmi Benda, MD, Jennifer De Los Santos, MD, Karen E.

William L. Lanier, MD Mayo Clinic Proceedings

Influence of robotic-assisted laparoscopic hysterectomy on vaginal cuff healing and brachytherapy initiation in endometrial carcinoma patients John M.

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.

Clinical evaluation of interfractional variations for whole breast radiotherapy using 3- dimensional surface imaging Amish P. Shah, PhD, Tomas Dvorak,

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary Lawrence B. Marks, MD, Robert.

Brenda G. Clark, PhD, Robert J

Effect of bra use during radiation therapy for large-breasted women: Acute toxicity and treated heart and lung volumes Lanea M.M. Keller, MD, MS, Randi.

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients.

Required target margins for image-guided lung SBRT: Assessment of target position intrafraction and correction residuals Chirag Shah, MD, Larry L. Kestin,

Jonathan A. Abelson, MD, James D. Murphy, MD, MS, Ellen A

Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree Justin M. Haseltine, BSE,

Safety of differential radiation dosing in lymph node positive necks treated with IMRT Stephen Sozio, MBS, Zorimar Rivera-Núñez, PhD, Omar Mahmoud, MD,

My Path from Hiroshima to Houston

US radiation oncology practice patterns for posttreatment survivor care Bridget F. Koontz, MD, Rashmi Benda, MD, Jennifer De Los Santos, MD, Karen E.

Gemcitabine and Irinotecan for Patients with Untreated Extensive Stage Small Cell Lung Cancer: SWOG 0119 Wallace Akerley, MD, Jason McCoy, MS, Paul J.

Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer

Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality.

Clinical outcome in patients with mild and moderate carotid artery stenosis Brian F. Johnson, MD, Fabio Verlato, MD, Robert O. Bergelin, MS, Jean F. Primozich,

Impact of radiotherapy dose on dentition breakdown in head and neck cancer patients Mary P. Walker, DDS, PhD, Brian Wichman, MS, An-Lin Cheng, PhD, James.

Predictive value of embryo grading for embryos with known outcomes

A Pharmacogenomic Study of Docetaxel and Gemcitabine for the Initial Treatment of Advanced Non-Small Cell Lung Cancer W Jeffrey Petty, MD, Sommer N.

Phase II Trial of Paclitaxel and Cisplatin in Patients with Extensive Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Trial 9430 Thomas E.

American Society for Radiation Oncology's Performance Assessment for the Advancement of Radiation Oncology Treatment: A practical approach for informing.

Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia Caroline Mariano, MD, Diana N. Ionescu, MD, Winson.

Intramedullary Reactive Fibrosis as Mimic of Prostate Cancer Bone Metastasis on 11C- Choline Positron Emission and Computed Tomography Tyler Trump, BS,

Practical Radiation Oncology

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy Todd.

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596):

Effect of Daily and Every Other Day Stereotactic Body Radiation Therapy Schedules on Treatment-Related Fatigue in Patients With Hepatocellular Carcinoma

An Editorial Note: The Long Arm of Practical Radiation Oncology

Ronald C. Chen, MD, MPH, Karen E. Hoffman, MD, David J

Burnout and Resiliency in Canadian Oncology Residents: A Nationwide Resident and Program Director Survey Hannah Dahn, MD, Angela McGibbon, MD, David.

Safety considerations for IMRT: Executive summary

Erratum The American Journal of Human Genetics

Khaled Adil, MD, Marija Popovic, PhD, Fabio L. Cury, MD, Sergio L

Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American.

Should Large Cell Neuroendocrine Lung Carcinoma be Classified and Treated as a Small Cell Lung Cancer or with Other Large Cell Carcinomas? John M. Varlotto,

Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer.

Radiation recall precipitated by iodinated nonionic contrast

Image-guided drainage versus antibiotic-only treatment of pelvic abscesses: short-term and long-term outcomes Justin To, M.D., Diana Aldape, M.D., Andrei.

Michael Hsie, MD, Stefania Morbidini-Gaffney, MD, Leslie J

A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients with Extensive Small Cell Lung Cancer: CALGB 30104 Ramaswamy Govindan, MD, Xiaofei.

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors Sean M. Parker, BS, R. Alfredo Siochi,

Charles A. Herzog Kidney International

Management of Mediastinal Relapse after Treatment with Stereotactic Body Radiotherapy or Accelerated Hypofractionated Radiotherapy for Stage I/II Non–Small-

Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018 Thomas M. Pisansky, MD, Ian M. Thompson,

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

Treatment versus Transplant for Challenging Hematologic Disorders

Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case-control study

D. Emerick Szilagyi, MD—An appreciation

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non- small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339)

A Review of First-Line Treatment for Small-cell Lung Cancer

Presentation transcript:

Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade Gliomas Kripa Guram, BS, Mark Smith, MD, Timothy Ginader, MS, Kellie Bodeker, MS CCRC, Darrin Pelland, RT(RT) CMD, Edward Pennington, MS, John M. Buatti, MD Practical Radiation Oncology Volume 9, Issue 1, Pages 16-23 (January 2019) DOI: 10.1016/j.prro.2018.06.001 Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

Figure 1 Progression-free and overall survival by margin size Practical Radiation Oncology 2019 9, 16-23DOI: (10.1016/j.prro.2018.06.001) Copyright © 2018 American Society for Radiation Oncology Terms and Conditions